Rebalix
LGIM · sheet of 20 October 2026
LGIM · sheet of 20 October 2026ETF sheet · official issuer and register data
L&G Gold Mining UCITS ETF
AUCO · IE00B3CNHG25 · class USD Acc. · USD · domicile Ireland
Equity · Global · Gold & silver minersSFDR art. 6
Index tracked: Global Gold Miners Index NTR
- TER
- 0.55%+ trans. 0.04%
- Fund size
- 823 m EUR
- Tracking difference
- −0.94%3-year avg
- 🇮🇹 tax rate
- —white list not published
- Replication
- Physical (full replication)
- Income
- Accumulating
Launch 6 Nov 2008 · costs from the KID as of 2 Oct 2026 · 44 securities held · 13 venues (ESMA register)
The fund’s objective — in the issuer’s words
From the Key Information Document (KID) · 2 Oct 2026
The investment objective of the Fund is to provide exposure to international gold mining companies that are actively engaged in the mining and production of gold ore. The Fund is passively managed and aims to track the performance of the Global Gold Miners Index (the “Index”), before the deduction of fees and expenses. The Index is designed to provide exposure to global companies that are actively engaged in gold mining and related activities, in accordance with its methodology.
The Fund seeks to achieve its investment objective by investing primarily…
Performance since series start (in euro) — base 100
29 Jul 2016 → 31 Aug 2026 · dividends reinvested where declared by the issuer · converted at ECB rates
Returns in euro
| 1 year | +64.8% |
| 3 years | +308.3% |
| 5 years | +301.5% |
| 10 years | +468.5% |
| Since series start | +382.0% |
Risk · 1 / 3 / 5 years
| Volatility (ann.) | 46.03% | 36.76% | 34.64% |
| Max drawdown | −39.07% | −39.07% | −48.70% |
| Sharpe | 0.36 | 1.30 | 0.79 |
| Sortino | 0.50 | 1.90 | 1.14 |
Sharpe/Sortino: risk-free = ECB MRO avg; nominal volatility
Rebalix · AUCO · IE00B3CNHG251
RebalixAUCO · IE00B3CNHG25 · sheet of 20 October 2026
Tracking difference — year by year
Fund minus index, complete calendar years · from issuer-declared series
| Year | Fund | Index | TD |
|---|---|---|---|
| 2025 | +180.86% | +182.44% | −1.57% |
| 2024 | +18.28% | +18.92% | −0.64% |
| 2023 | +16.28% | +16.90% | −0.62% |
| 2022 | −15.32% | −15.45% | +0.12% |
| 2021 | −9.50% | −9.17% | −0.33% |
Holdings
Portfolio as declared by the issuer · 1 Oct 2026 · 44 securities · top-10 weight = 68.0%
| Top holdings | Weight |
|---|---|
| 16.1% | |
| 11.3% | |
| 9.5% | |
| 6.4% | |
| 6.0% | |
| 5.4% | |
| 4.8% | |
| 3.5% | |
| 2.6% | |
| 2.5% |
Countries (% of fund)
Sectors (% of fund)
Listing venues
ESMA register (FIRDS) and official exchange lists
AUCON · Bolsa Mexicana de Valores
AUCO · Borsa Italiana (ETFplus), Euronext Amsterdam, London Stock Exchange, SIX Swiss Exchange
ETLX · Börse Düsseldorf, Börse Frankfurt, Börse Hamburg, Börse Hannover, Börse München / gettex, Börse Stuttgart, Tradegate Exchange, Xetra (Deutsche Börse)
+ 6 unmapped venues (MTF, RFQ, professional)
Official documents
Clickable links in the PDF
The live sheet, always up to date
rebalix.com/en/etf/IE00B3CNHG25
Series, distributions, holdings and documents refresh daily.
rebalix.com/en/etf/IE00B3CNHG25
Series, distributions, holdings and documents refresh daily.
Sheet produced on 20 October 2026 · data as of the dates shown section by section. Sources: official issuer documents (KID, factsheet, NAV and total-return series, declared portfolio), ESMA register (FIRDS), European Central Bank (FX), Italian tax authority / issuer (white-list share). Public methodology: rebalix.com/en/methodology. “—” = not published by the source, never estimated.
Informational document generated by rebalix.com: facts only, no recommendations. Not investment advice or investment research under Directive 2014/65/EU (MiFID II), nor an offer or solicitation. Past performance is not indicative of, nor a guarantee of, future results; the value of an investment can go down as well as up. Before any decision read the issuer’s KID and Prospectus; tax treatment depends on individual circumstances. Trademarks and logos belong to their respective owners and only identify the instrument and its issuer: no affiliation, sponsorship or endorsement.
Rebalix · AUCO · IE00B3CNHG252